NAMI
CPRX

Nomura Asset Management International’s Catalyst Pharmaceutical CPRX Stock Holding History

Nomura Asset Management International’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5M Sell
748,104
-30,487
-4% -$726K 0.03% 575
2025
Q4 		$18.2M Buy
+778,591
New +$17.3M 0.03% 603

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nomura Asset Management International's CPRX Position: Q1 2026 in Review

Nomura Asset Management International reduced its Catalyst Pharmaceutical (CPRX) stake by 3.9% in Q1 2026, selling an estimated $726K and leaving 748,104 shares worth $18.5M. The position accounts for 0.03% of the portfolio, ranked #575.

Nomura Asset Management International first reported a position in CPRX in Q4 2025 and has held it in 2 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Nomura Asset Management International held 748,104 shares of Catalyst Pharmaceutical worth $18.5M as of Q1 2026.
  • Nomura Asset Management International sold 30,487 Catalyst Pharmaceutical shares in Q1 2026, an estimated $726K.
  • Catalyst Pharmaceutical made up 0.03% of Nomura Asset Management International's portfolio in Q1 2026, its #575 holding.
  • Nomura Asset Management International first reported a position in Catalyst Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Nomura Asset Management International's 13F filing for Q1 2026, filed 15 May 2026.